title: Long-term molecular efficacy and safety of imatinib in a patient with chronic myeloid leukaemia after renal transplantation.
authors.forename: Antoine
authors.initials: A
authors.lastname: Thierry
authors.forename: Brigitte
authors.initials: B
authors.lastname: Dreyfus
authors.forename: Frank
authors.initials: F
authors.lastname: Bridoux
authors.forename: Ramzi
authors.initials: R
authors.lastname: Abou Ayache
authors.forename: Serge
authors.initials: S
authors.lastname: Milin
authors.forename: François
authors.initials: F
authors.lastname: Guilhot
authors.forename: Guy
authors.initials: G
authors.lastname: Touchard
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001549:Benzamides; D003928:Diabetic Nephropathies / Q000188:drug therapy / Q000201:enzymology / Q000601:surgery; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D007676:Kidney Failure, Chronic / Q000188:drug therapy / Q000201:enzymology / Q000601:surgery; D016030:Kidney Transplantation; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000201:enzymology; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D047428:Protein Kinase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D011743:Pyrimidines / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate